Surgical Innovations GroupLSE:SUN Shareholder Yield % is 11.07% as of Dec. 2025, which is 273% above its 10-year median of 2.97. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Surgical Innovations Group ranks better than 94.12% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Surgical Innovations Group's Shareholder Yield % was 11.07%.
Surgical Innovations Group (LSE:SUN) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Surgical Innovations Group Shareholder Yield % Related Terms
Surgical Innovations Group Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group Shareholder Yield % Chart
LSE:SUN vs ABT, SYK, MDT: Shareholder Yield % Comparison
For the Medical Devices subindustry, Surgical Innovations Group's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Surgical Innovations Group (LSE:SUN) has a Shareholder Yield % of 11.07% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Surgical Innovations Group and its competitors. This is 273% above median its historical median of 2.97. According to the industry distribution chart, Surgical Innovations Group ranks #48 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 5.9%.
Is Surgical Innovations Group's Shareholder Yield % too high?
Surgical Innovations Group's current Shareholder Yield % of 11.07% is 273% above median its 10-year median of 2.97. The Medical Devices & Instruments industry median Shareholder Yield % is 0.16. Surgical Innovations Group's value of 11.07% is 6818.8% above this industry median. Based on the distribution chart, Surgical Innovations Group ranks #48 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Surgical Innovations Group's Shareholder Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #48 out of 817 companies for Shareholder Yield %. This places Surgical Innovations Group in the top 6% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.16. Surgical Innovations Group's value of 11.07% is 6818.8% above this benchmark. While the company's 10-year median is 2.97 vs. the industry median of 0.16, Surgical Innovations Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.16, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current Shareholder Yield % of 11.07% is 6818.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current Shareholder Yield % is 11.07%, which is 273% above median its own 10-year median of 2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.01 — trading 50% below its estimated fair value. The current Shareholder Yield % is 11.07%, which is 273% above median its 10-year median of 2.97 and 6818.8% above the Medical Devices & Instruments industry median of 0.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Shareholder Yield % is 11.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 